You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 29, 2024

Details for Patent: 8,436,180


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,436,180 protect, and when does it expire?

Patent 8,436,180 protects KERENDIA and is included in one NDA.

This patent has fifty-nine patent family members in forty-five countries.

Summary for Patent: 8,436,180
Title:Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof
Abstract: The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.
Inventor(s): Barfacker; Lars (Oberhausen, DE), Kolkhof; Peter (Wuppertal, DE), Schlemmer; Karl-Heinz (Wuppertal, DE), Grosser; Rolf (Leverkusen, DE), Nitsche; Adam (Pulheim, DE), Klein; Martina (Heiligenhaus, DE), Munter; Klaus (Wulfrath, DE), Albrecht-Kupper; Barbara (Wulfrath, DE), Hartmann; Elke (Wuppertal, DE)
Assignee: Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:12/526,951
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Process;

Drugs Protected by US Patent 8,436,180

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare KERENDIA finerenone TABLET;ORAL 215341-001 Jul 9, 2021 RX Yes No ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
Bayer Hlthcare KERENDIA finerenone TABLET;ORAL 215341-002 Jul 9, 2021 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,436,180

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2007 009 494Feb 27, 2007
PCT Information
PCT FiledFebruary 19, 2008PCT Application Number:PCT/EP2008/001257
PCT Publication Date:September 04, 2008PCT Publication Number: WO2008/104306

International Family Members for US Patent 8,436,180

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 065463 ⤷  Try a Trial
Australia 2008221071 ⤷  Try a Trial
Brazil 122020008544 ⤷  Try a Trial
Brazil PI0808098 ⤷  Try a Trial
Canada 2679232 ⤷  Try a Trial
Chile 2008000502 ⤷  Try a Trial
China 101641352 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.